EE313 Utilisation of the Cost-Saving Impact of Biosimilar Switching in Ophthalmological Diseases in the NHS: A Case-Study for a Ranibizumab Biosimilar
| Autor: | Keady, S., Rickard, I., Xin, Q., Morris, L., Thomas, M., Foxon, G. |
|---|---|
| Zdroj: | In Value in Health June 2023 26(6) Supplement:S116-S116 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect